Last reviewed · How we verify

NCT04179578: PEH2

The Value of Lateral Release in Reconstruction of the Diaphragmatic Hiatus Hernia

Active, enrolled NA Last updated 22 October 2024
What this trial tests

NA trial testing Crura plastic in Paraesophageal Hernia in 70 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
16 July 2019
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorKarolinska Institutet
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment70
Start date16 July 2019
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Karolinska Institutet

Who can join

18 and older, any sex, with Paraesophageal Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients scheduled for surgery for primary paraesophageal herniation are randomized to either conventional suturing of the crura or with the addition of lateral release.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The value of "diaphragmatic relaxing incision" for the durability of the crural repair in patients with paraesophageal hernia: a double blind randomized clinical trial.
    Tsoposidis A, Thorell A, Axelsson H, Reuterwall Hansson M, et al · · 2023 · cited 2× · PMID 38026477 · DOI 10.3389/fsurg.2023.1265370

Verify or expand the search:

Other recruiting trials for Paraesophageal Hernia

Currently open trials in the same condition.

Other Karolinska Institutet trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04179578.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing